Vascular Biology Working Group

Website Managed & Supported By:

VBWG US Chapter Meeting
Friday March 23, 2012
5:00 pm - 9:00 pm

Autologous CD34+ Cell Therapy for Critical Limb Ischemia
Douglas W. Losordo, MD
Northwestern University
Chicago, Illinois

Progressive Visual Loss in Type 2 Diabetes
Robert J. Chilton, DO
University of Texas Health Science Center
San Antonio, Texas

Undiagnosed Type 2 Diabetes and Long-term CV Risk Reduction
Paresh Dandona, MBBS, Dphil, FRCP,
FACP, FACC, FACE
University at Buffalo
The State University of New York
Buffalo, New York

Role of Platelet Reactivity in Science and Practice
Jane E. Freedman, MD
Professor of Medicine and Pharmacology
Boston University School of Medicine
Boston, Massachusetts

Blood Pressure Control in the Age of Combination Therapy in CV Risk Reduction: What Have We ACCOMPLISHed?
George L. Bakris, MD, FASN, FAHA
The University of Chicago
Pritzker School of Medicine
Chicago, Illinois


	Contemporary Management of Cardiometabolic Risk 105 slides and content points

		Advanced


Home \| Literature Update \| Journal Link \| Resources \| Meeting Highlights \| Members \| About VBWG \| Web Links